I would not be overly concerned at those levels J. details should be standard.
In any case funding comes on the balance sheet so CRs are a neutral event, its the purpose that's important here.
If it was to prop up the co in times of need then it is a devaluation to SH, if it is for an expansion that brings revenue in a foreseeable timeline it is a SH benifit.
If you didn't see this coming in light of management anns and the trading pattern, I can't help you. But don't fall for that CRs are co killers a myth, they are co nutral its what mgmt do with the reddies that counts to value growth...
- Forums
- ASX - By Stock
- FDM
- placement
placement, page-5
-
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FDM (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online